NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,700,586 | +33.7% | 15,704 | +12.9% | 0.02% | +30.8% |
| Q1 2024 | $1,272,209 | +43.0% | 13,910 | -2.1% | 0.01% | +18.2% |
| Q4 2023 | $889,864 | +38.6% | 14,206 | -2.1% | 0.01% | +22.2% |
| Q3 2023 | $641,891 | -7.4% | 14,506 | +1.8% | 0.01% | 0.0% |
| Q2 2023 | $693,162 | -0.8% | 14,245 | +13.2% | 0.01% | -10.0% |
| Q1 2023 | $698,941 | +45.0% | 12,589 | +4.9% | 0.01% | +25.0% |
| Q4 2022 | $481,919 | +14.2% | 11,997 | +24.7% | 0.01% | 0.0% |
| Q3 2022 | $422,000 | +24.9% | 9,619 | +0.8% | 0.01% | +14.3% |
| Q2 2022 | $338,000 | -9.4% | 9,543 | +4.0% | 0.01% | +16.7% |
| Q1 2022 | $373,000 | -55.0% | 9,180 | +3.6% | 0.01% | -53.8% |
| Q4 2021 | $828,000 | -14.2% | 8,864 | +2.4% | 0.01% | -27.8% |
| Q3 2021 | $965,000 | +0.2% | 8,660 | +2.1% | 0.02% | 0.0% |
| Q2 2021 | $963,000 | +352.1% | 8,478 | +295.4% | 0.02% | +260.0% |
| Q4 2020 | $213,000 | – | 2,144 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |